Cargando…
Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
AIMS: Despite recent advances in the treatment of chronic heart failure (HF), mortality and hospitalizations still remain high. Additional therapies to improve mortality and morbidity are urgently needed. The efficacy of cardiac glycosides – although regularly used for HF treatment – remains unclear...
Autores principales: | Bavendiek, Udo, Berliner, Dominik, Dávila, Lukas Aguirre, Schwab, Johannes, Maier, Lars, Philipp, Sebastian A., Rieth, Andreas, Westenfeld, Ralf, Piorkowski, Christopher, Weber, Kristina, Hänselmann, Anja, Oldhafer, Maximiliane, Schallhorn, Sven, von der Leyen, Heiko, Schröder, Christoph, Veltmann, Christian, Störk, Stefan, Böhm, Michael, Koch, Armin, Bauersachs, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607489/ https://www.ncbi.nlm.nih.gov/pubmed/30892806 http://dx.doi.org/10.1002/ejhf.1452 |
Ejemplares similares
-
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial
por: Bavendiek, Udo, et al.
Publicado: (2023) -
COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI)
por: Smith, Douglas H., et al.
Publicado: (2021) -
Right Ventricular Function Improves Early After Percutaneous Mitral Valve Repair in Patients Suffering From Severe Mitral Regurgitation
por: Neuser, Jonas, et al.
Publicado: (2022) -
Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020) -
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)